Stryker
SYK · NYSE
About SYK
- Employees
- 56,000
- Headquarters
- Portage, Michigan
- Listed
- Mar 17, 1980
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Website
- stryker.com
SYK key statistics
- Market cap
- 116.76B
- Price-earnings ratio
- 30.87
- Dividend yield
- 1.13%
- Average volume
- 2.54M
- Volume
- 3.17M
- Open price
- $302.29
- High today
- $305.03
- Low today
- $298.93
- 52 Week high
- $392.55
- 52 Week low
- $267.00
Stryker (SYK) at a glance
Stryker (SYK) last traded at $304.40, with a market cap of 116.76B, a price-to-earnings ratio of 30.87 and a dividend yield of 1.13%.
Today the stock has traded between $298.93 and $305.03. The current price is 1.8% above the day's low and 0.2% below its high.
Volume so far is 3.17M shares, above the average of 2.54M shares a day.
Over the past year Stryker has ranged from $267.00 to $392.55, and now sits 30% of the way up that range.
Stryker met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported $3.69 per share against an estimate of $3.52.
The average analyst price target is $377.13, 23.9% above the current price, from 22 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy77.3%
- Hold22.7%
- Sell0.0%
- Low
- $300.98
- Now
- $304.40
- High
- $488.25
SYK earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 5 of the last 8 quarters, by 1.7% on average.
- Q4 FY99: reported $0.13 per share against an estimate of $0.1281
- Q1 FY00: reported $0.13 per share against an estimate of $0.1292
- Q2 FY00: reported $0.13 per share against an estimate of $0.1328
- Q3 FY00: reported $0.125 per share against an estimate of $0.1288
- Q3 FY25: reported $3.19 per share against an estimate of $3.16
- Q4 FY25: reported $4.47 per share against an estimate of $4.44
- Q1 FY26: reported $2.60 per share against an estimate of $3.01
- Q2 FY26: reported $3.69 per share against an estimate of $3.52
SYK news
- Press releaseGlobe Newswire
- Press releaseGlobe Newswire
Stryker Corporation (SYK) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
- Press releaseGlobe Newswire
Securities Fraud Investigation Into Stryker Corporation (SYK) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
- Press releasePRNewswire
Stryker launches Sonopet® 3, delivering greater power and precision in ultrasonic tissue removal
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK
10 Health Care Stocks With Whale Alerts In Today’s Session
- Vandana Singh
Stryker Makes $400 Million Robotic Surgery Bet
10 Health Care Stocks With Whale Alerts In Today’s Session
Similar companies
Companies in the same industry as Stryker
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.